Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.43 USD | -0.73% | -2.96% | -8.35% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.